Xu Junming, Zhang Yingying, Liu Jun, Qiu Shenglong, Wang Min
Department of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
J Int Med Res. 2021 Feb;49(2):300060520984618. doi: 10.1177/0300060520984618.
To explore the clinicopathological features and relative prognostic risks of the three major variants of papillary thyroid carcinoma (PTC).
We retrospectively analyzed the clinicopathological characteristics and prognoses of patients with the three major PTC variants, conventional papillary thyroid carcinoma (CPTC), follicular-variant papillary carcinoma (FVPTC), and tall-cell papillary thyroid carcinoma (TCPTC), based on data from the Surveillance, Epidemiology, and End Results database from 2005 to 2009.
A total of 29,555 patients were enrolled. In terms of their demographic and clinicopathological characteristics, TCPTC had the highest prevalence of older patients, men, patients with locally advanced stage (T stage and N stage), and mortality, while FVPTC had the lowest prevalence in relation to these factors. The three variants differed significantly in terms of 5-year overall survival and 5-year disease-specific survival. Cox regression analysis identified male sex, age ≥45 years, and higher American Joint Committee on Cancer and TNM stage as independent factors predicting a poor prognosis in relation to both overall and disease-specific survival.
CPTC, FVPTC, and TCPTC have different clinicopathological characteristics and prognoses, indicating the need for different treatment strategies for these three variants of PTC.
探讨甲状腺乳头状癌(PTC)三种主要变体的临床病理特征及相关预后风险。
基于2005年至2009年监测、流行病学和最终结果数据库的数据,我们回顾性分析了三种主要PTC变体患者的临床病理特征及预后,这三种变体分别为传统甲状腺乳头状癌(CPTC)、滤泡变体乳头状癌(FVPTC)和高细胞甲状腺乳头状癌(TCPTC)。
共纳入29555例患者。就人口统计学和临床病理特征而言,TCPTC在老年患者、男性、局部晚期(T分期和N分期)患者及死亡率方面的患病率最高,而FVPTC在这些因素方面的患病率最低。这三种变体在5年总生存率和5年疾病特异性生存率方面存在显著差异。Cox回归分析确定男性、年龄≥45岁以及美国癌症联合委员会和TNM分期较高是预测总生存和疾病特异性生存预后不良的独立因素。
CPTC、FVPTC和TCPTC具有不同的临床病理特征和预后,表明这三种PTC变体需要不同的治疗策略。